Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study

Table 2

Prulifloxacin treatment characteristics.

Prulifloxacin treatment characteristics
Prulifloxacin administration at the recommended dose of 600 mg once daily (N = 302), n (%)	297 (98.3)
Prulifloxacin treatment duration (N = 298), mean (SD), days	9.53 (1.28)
Patients’ distribution per treatment duration in days (N = 302), n (%)
≤6	11 (3.6%)
7	23 (7.6%)
8	6 (2.0%)
9	7 (2.3%)
10	255 (84.4%)
Prulifloxacin tablets taken (N = 302), mean (SD)	9.53 (1.28)

SD: standard deviation.